This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Suzhou Smartnuclide Biopharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yanling Yang - Innovator in Biomedicine
Introduction
Yanling Yang is a prominent inventor based in Suzhou, China. She has made significant contributions to the field of biomedicine, particularly in the development of polypeptides that bind to PD-L1. Her work is crucial in the detection and diagnosis of PD-L1 related diseases, including various forms of cancer.
Latest Patents
Yanling Yang holds a patent for a PD-L1-binding polypeptide and its applications. This invention is pivotal in advancing medical diagnostics and therapeutic strategies for cancer treatment. The patent highlights her innovative approach to addressing critical health challenges.
Career Highlights
Yang is associated with Suzhou Smartnuclide Biopharmaceutical Co., Ltd., where she continues to push the boundaries of biopharmaceutical research. Her expertise and dedication have positioned her as a key figure in her field.
Collaborations
She collaborates with notable colleagues, including Tao Xu and Yan Sun, who contribute to her research endeavors. Their combined efforts enhance the impact of their work in biomedicine.
Conclusion
Yanling Yang's contributions to biomedicine through her innovative patents and collaborations underscore her importance in the field. Her work not only advances scientific knowledge but also holds promise for improving cancer diagnostics and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile